FDA Basics Webinar: A Brief Overview of Risk Evaluation and Mitigation Strategies (REMS)
In 2007, a new law that gave FDA many new authorities and responsibilities to enhance drug safety was enacted. It's called the Food and Drug Administration Amendments Act- sometimes called "FDAAA"- and one of its provisions gave FDA the authority to require a Risk Evaluation and Mitigation Strategy-(REMS) from manufacturers to ensure that the benefits of a drug or biological product outweigh its risks.
A REMs may be required by the FDA as part of the approval of a new product, or for an approved product when new safety information arises. Essentially, a REMS is a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.
Since medicines are very different from each other, each REMS for each medicine is also different.
This presentation discussed REMS and how they are used to help ensure that the benefits of certain medicines continue to outweigh their risks.
A Brief Overview of Risk Evaluation and Mitigation Strategies (REMS)
Adobe Connect link
FDA Basics Webinar: A Brief Overview of REMS(PDF - 1.2MB)
Download Presentation Slides
- What do consumers need to know about the recall of shell eggs?
- What should I do if I have a serious reaction (side effect) to a cosmetic product?
- When previously recalled products are back on the shelves, how can I be sure that it is okay to buy them?
- FDA Basics Webinar - September 23, 2015: The National Antimicrobial Resistance Monitoring System (NARMS): Protecting the American Public from Foodborne Illness
- How does FDA recommend washing fruits and vegetables?
- How long can I keep my food in the refrigerator/on the shelf?
- What is FDA doing to lower/reduce the risk of childhood obesity?
- Food Allergies: Is my child at risk?
- How does FDA provide information about drug products currently under review for approval by the agency?
- Why are some drugs available as both a prescription and an over-the-counter drug?
- FDA Basics Webinar August 19, 2013: Biological Products, Part 2: Biosimilar Biological Products
- FDA Basics Webinar, June 17, 2013: Biological Products: Part 1
- FDA Basics Webinar on Advice to Dog Owners Whose Pets Take NSAIDS
- FDA Basics Webinar- August 31, 2015: Food Safety: Bad Weather Basics
- What is a biological product?
- July: CBER's Direct Recall Classification Program
- Webinar on FDA’s Safety Monitoring of Approved Vaccines
- What part of FDA regulates tobacco products?
- FDA Basics – OCTGT Webinar on Tissue Safety
- FDA Webinar on Safety of the Blood Supply
- FDA Webinar on Protecting Your Child's Health Through Safe and Effective Vaccines
- What are stem cells? How are they regulated?
- FDA Basics Webinar: State Enforcement Program
- How does FDA plan to enforce the restrictions on promotion and advertising established by the Tobacco Control Act?
- Does FDA have the authority to regulate tobacco products?
How helpful was this information?